Table 5.

AI at baseline and after using wraparound (placebo) and percentage reduction of OSAS

Patient	AI		Reduction (%)
	Baseline	After use
1	6.4	6.0	6.4
2	2.3	0.4	84.1
3	2.1	0.4	82.9
4	4.9	11.6	−137.1
5	1.6	6.3	−301.9
6	16.3	22.6	−38.4
7	6.3	23.2	−269.9
8	2.1	0.5	75.7
9	9.3	0.8	91.3
10	1.2	2.6	−119.3
11	3.1	0	100.0
12	4.1	11.2	−172.4
13	13.9	0.6	95.9
14	8.1	13.7	−68.5
15	2.0	0.7	66.0
16	1.9	2.4	−25.7
17	3.7	0.6	84.3
18	15.2	26.0	−71.0
19	3.3	13.0	−296.0
Mean	5.7	7.5	−42.8
SD	4.8	8.7	139.5